Nobivac for Canine 1-DAPPv (25 Doses) - [Vaccine]

Nobivac Canine 1-DAPPv is a modified live virus vaccine designed for use in healthy dogs 6 weeks of age or older. It helps protect against multiple highly contagious and potentially fatal canine diseases, including canine distemper virus, adenovirus type 1 (hepatitis), adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus.

This proven 1-year vaccine offers broad-spectrum protection and is formulated with high antigenic mass to stimulate a strong immune response.

Click here to view the official product datasheet (PDF)

Key Benefits of Nobivac Canine 1-DAPPv

• Protects against all known strains of canine parvovirus (CPV), including the emerging CPV-2c variant^1,2
• High antigenic mass (titer), low passage parvovirus vaccine for strong immunity
• Contains CPV-2b, one of the most prevalent and protective parvovirus field strains
• Dual adenovirus protection: hepatitis (type 1) and respiratory infection (type 2)
• Combines five critical viral protections into one convenient formula
• First vaccine with published data showing efficacy against CPV-2c challenge¹
• Proven ability to override maternal antibodies for reliable early-age vaccination³

Indications

• Indicated for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus types 1 and 2, canine parainfluenza virus, and canine parvovirus
• Recommended for puppies and dogs 6 weeks of age or older

Aseptically transfer the entire contents of the sterile diluent vial into the vial containing Nobivac Canine 1-DAPPv. Gently mix until fully dissolved. Use the entire contents immediately after rehydration.

Administer one dose (1 mL) by subcutaneous or intramuscular injection. The initial dose may be given to puppies as early as 6 weeks of age. Repeat every 2 to 4 weeks until the dog is 12 weeks of age. A minimum of two doses is required for primary immunization.

Annual revaccination with a single 1 mL dose is recommended. Per the American Veterinary Medical Association (AVMA) Vaccination Principles, an appropriate revaccination schedule should be determined by the attending veterinarian based on a veterinarian-client-patient relationship.

• Administer subcutaneously or intramuscularly.
• Begin primary vaccination at 6 weeks of age or older; repeat at 2–4 week intervals until 12 weeks of age.
• Annual revaccination with 1 dose is recommended. Schedule should follow AVMA Vaccination Principles and veterinary discretion.

Safety Information

Please refer to the official product label for full safety details and administration guidelines.

Precautions

• Store at 2°C–7°C (36°F–45°F). Do not freeze.
• Do not mix with other vaccines or medications.
• Use only sterile, non-chemically sterilized needles and syringes.
• Burn vaccine container and any unused contents after use.

Warnings

• Contains gentamicin as a preservative.
• Administer only to healthy, non-parasitized dogs.
• Do not vaccinate pregnant bitches.
• Use of any biological product may cause hypersensitivity reactions such as anaphylaxis. Antidote: Epinephrine, corticosteroids, and/or antihistamines may be indicated depending on severity.
• Maternal antibody interference with parvovirus immunity varies based on maternal titer and colostral antibody absorption in the puppy.